Navigation Links
Generation of Fully Human Monoclonal Antibodies Neutralizing Influenza Virus - Use of SPYMEG as a novel human lymphocyte fusion partner
Date:1/26/2010

NAGOYA, Japan, Jan. 26 /PRNewswire/ -- Medical & Biological Laboratories Co., Ltd. (MBL), with the collaboration of Osaka University, has successfully generated several fully human monoclonal antibodies against pandemic A (H1N1 and H3N2) type influenza virus by utilizing blood samples from volunteers who were inoculated with influenza vaccine.

Professor Kazuyoshi Ikuta, Ph. D., at the Department of Virology, Research Institute for Microbial Diseases, Osaka University, has confirmed through in vitro experiments that the fully generated human antibodies can neutralize H3N2 influenza virus strains. Professor Ikuta is now evaluating the preventative and therapeutic effects in an infected mouse model. After completing in vivo experiments in infected animal models with the neutralizing antibodies, MBL plans to commence a collaborative clinical development program with a pharmaceutical company. These neutralizing human IgG antibodies against the influenza virus are expected to be effective in severe infections. In combination with anti-viral drugs these antibodies will have greater success than anti-viral drugs alone.

The therapeutic antibodies were generated by using a special cell line, called SPYMEG. This novel cell line is a human lymphocyte fusion partner, it was co-developed by associate professor Naomasa Yamamoto, Ph. D., of Ohu University and MBL. SPYMEG is the cell line established by the cell fusion of MEG-01 with a murine myeloma cell line. Hybridoma cells of human origin are known to be prone to chromosome deletions. The SPYMEG cell line overcomes that problem, resulting in a higher reliability of cell fusion. Utilization of SPYMEG is a simpler and easier way to generate therapeutic monoclonal antibodies than chimerization, or humanization of mouse
'/>"/>

SOURCE MBL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Osteotech Submits 510(k) Application to FDA for Clearance of its Duratech(TM) BioRegeneration Matrix
2. Indiana Industry, University and Community Leaders Capitalize on Next Generation of States Life Sciences Growth
3. DONG Energy and Inbicon Inaugurate One of the Worlds Largest Demo Plants for 2nd Generation Biofuel
4. DuPont, Dow AgroSciences Agree to Cross License Next-Generation Soybean Herbicide Tolerant Traits
5. UD wins $4.4 million to develop next-generation magnets
6. Pieris Reports Preclinical Development Progress of its Next Generation VEGF Antagonist
7. Parameter Generation and Control Launches New Catalog "Pharmaceutical Stability Solutions"
8. Boston Biotech R&D Conference to Showcase Next-Generation Newsmakers and Massachusetts as Leader in Biotech Discovery
9. Ontario Institute for Cancer Research Validates NEBNext(TM) DNA Sample Preparation Reagents from New England Biolabs for use in Next Generation Sequencing
10. Boston Scientific Announces Release of Next-Generation iLab(R) System Software
11. Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Charm Sciences, Inc. is pleased to ... Grain Inspection, Packers and Stockyards Administration (GIPSA) has ... to monitor aflatoxin in grains utilizing Charm’s ROSA ... Aflatoxin Quantitative Test (solvent-based). , The Charm ... Extraction Technology to extract aflatoxin from the sample ...
(Date:5/21/2015)... TORONTO , May 21, 2015 /PRNewswire/ - SQI ... SQIDF),a life sciences company that develops and commercializes proprietary ... its financial and operational results for the second fiscal ... the quarter the Company continued to advance business with ... Andrew Morris , President and CEO of SQI. ...
(Date:5/21/2015)... , May 21, 2015  Susan Hedstrom, Executive ... a nonprofit organization dedicated to supporting research to ... (PWS), announced today that FPWR has received the ... Irina Shaulov contributed $1 million in support ... "Our gift ...
(Date:5/21/2015)... 2015  The EveryLife Foundation for Rare Diseases ... Amy Klobuchar (D-MN) today for introducing ... Treatments, or OPEN ACT. Supported by ... this bipartisan legislation promises to rapidly bring hundreds ... disease patients by incentivizing drug makers to "repurpose" ...
Breaking Biology Technology:USDA-GIPSA (FGIS) Awards 5 Year Contract for Aflatoxin Tests to Charm Sciences 2SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8The Foundation for Prader-Willi Research Receives $1M Contribution in Support of Clinical Initiatives 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2
... 8 A study in the June issue of ... demonstrates that the Hepascore(TM) liver fibrosis blood-serum test panel ... fibrosis in patients with chronic hepatitis C (HCV), potentially ... care for staging fibrosis, in a particular subset of ...
... Interactive Agency Recognized for Excellence in Healthcare Marketing , ... Group , the premier strategic interactive marketing agency serving ... the 2009 Aster Awards with the ... healthcare marketing campaigns for DePuy Orthopaedics and AstraZeneca. ...
... , Amerinet Offering AccuVein,s AV300 Hand-Held Vein Illumination Device to ... June 8 AccuVein LLC today announced a three year ... world,s first hand-held, non-contact vein illumination device to its members. ... a patient,s skin revealing vein position to help the healthcare ...
Cached Biology Technology:Study Finds Noninvasive Blood Test for Liver Fibrosis May Alleviate Need for Liver Biopsies for Some Patients with Chronic Hepatitis C 2Study Finds Noninvasive Blood Test for Liver Fibrosis May Alleviate Need for Liver Biopsies for Some Patients with Chronic Hepatitis C 3Study Finds Noninvasive Blood Test for Liver Fibrosis May Alleviate Need for Liver Biopsies for Some Patients with Chronic Hepatitis C 4Cadient Group Brings Home the Gold and Two Bronze Aster Awards 2AccuVein Inks National Three-Year Group Purchasing Deal With Amerinet 2
(Date:4/20/2015)... Calif. , April 20, 2015 Huntington ... Gabriel Valley to implant a new miniaturized, wireless monitoring ... System is the first and only FDA-approved heart failure ... hospital admissions when used by physicians to manage heart ... sensor that is implanted in the pulmonary artery (PA) ...
(Date:4/13/2015)... According to a recently ... & Opportunities, 2020", the global biometrics market is ... till 2020. The biometrics market is garnering attention ... review of biometric management systems. The constant development ... greater efficiency, are resulting in increasing installation of ...
(Date:4/6/2015)... , Apr. 6, 2015 NXT-ID, Inc. ... a biometric authentication company focused on the growing ... filed provisional patent 62/143028 for MINIATURE, ... ENERGY TRANSFER  NXT-ID introduces a new ... This patent surrounds the use of miniature antenna ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
... demand for cargo transport, has inadvertently opened the flood ... has mapped the most detailed forecast to date for ... of cargo ships. Scientists from the Universities of ... data and biological records to assess the risk of ...
... the quality of life for many cancer patients. Many ... to DNA. The public has an opportunity to learn ... drugs and how laboratory research may lead to novel targets ... , a professor of chemistry at the University ...
... May 3, 2013 In a climate as prone ... heat, light and cool. Fortunately, innovative solutions are being ... Network (SNEBRN), a nationwide university initiative headquartered at Concordia, ... from Natural Resources Canada (NRCan). "Through the ...
Cached Biology News:Researchers calculate the global highways of invasive marine species 2Researchers calculate the global highways of invasive marine species 3How do anticancer drugs work? 2How do anticancer drugs work? 3$1 million for smart energy solutions 2
...
Mouse monoclonal [IFR0104] to Salmonella enteriditis ( Abpromise for all tested applications)....
Marmoset plasma and serum - various quantities available...
Natural Mouse Laminin is purified from the Engelbreth-Holm-Swarm (EHS) sarcoma and is provided in Tris-buffered saline....
Biology Products: